NOUVEL AGENT ANTI-TUMEUR MALIGNE BASÉ SUR LA SPÉCIFICITÉ DU MÉTABOLISME DES CELLULES CANCÉREUSES

• 收藏
• 分享

专利权人:

Delta-Fly Pharma; Inc.

发明人:

WADA Hiromi,HAMAGUCHI Reo

申请号：

EP17905913

公开号：

EP3456354A4

申请日:

2017.07.20

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

An object of the present invention is to provide a method for treatment or prevention of cancer, which not only exerts a great effect at low cost but also has few side effects. A combination drug containing a urinary alkalinization agent and vitamin C or a combination drug containing a urinary alkalinization agent, vitamin C and metformin for use in treatment or remission of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/